- Revenues of
$1.88 billion , approximately 6.3% growth; 5.3% organic growth(1) - Net income of
$102 million ; Adjusted EBITDA(1) of$193 million or 10.3% of revenues - Diluted earnings per share of
$2.38 ; Adjusted diluted earnings per share(1) of$3.01 - Cash flows provided by operating activities of
$146 million ; Free cash flow(1) of$131 million - Net bookings of
$1.2 billion ; quarterly book-to-bill ratio of 0.6; trailing twelve months book-to-bill ratio of 0.8 - Company increases fiscal year 2027 guidance for revenue, adjusted EBITDA(1), adjusted EBITDA margin %(1) and adjusted diluted EPS(1); reiterates free cash flow(1) guidance
"I am proud of our team’s performance this quarter, delivering solid organic growth and double-digit margins as we continue to execute with discipline," said
Second Quarter of Fiscal Year 2027: Summary Operating Results
| Three Months Ended | ||||||||||
2026 | Percent change | 2025 | ||||||||
| (dollars in millions, except per share amounts) | ||||||||||
| Revenues | $ | 1,880 | 6% | $ | 1,769 | |||||
| Operating income | 152 | 9% | 139 | |||||||
| Operating income as a percentage of revenues | 8.1 | % | 20bps | 7.9 | % | |||||
| Adjusted operating income(1) | 191 | 5% | 182 | |||||||
| Adjusted operating income as a percentage of revenues | 10.2 | % | -10bps | 10.3 | % | |||||
| Net income | 102 | (20)% | 127 | |||||||
| EBITDA(1) | 193 | 9% | 177 | |||||||
| EBITDA as a percentage of revenues | 10.3 | % | 30bps | 10.0 | % | |||||
| Adjusted EBITDA(1) | 193 | 4% | 185 | |||||||
| Adjusted EBITDA as a percentage of revenues | 10.3 | % | -20bps | 10.5 | % | |||||
| Diluted earnings per share | $ | 2.38 | (12)% | $ | 2.71 | |||||
| Adjusted diluted earnings per share(1) | $ | 3.01 | (17)% | $ | 3.63 | |||||
| Net cash provided by operating activities | $ | 146 | 20% | $ | 122 | |||||
| Free cash flow(1) | $ | 131 | (13)% | $ | 150 | |||||
(1)Non-GAAP measure, see Schedule 6 for information about this measure.
Second Quarter Summary Results
Revenues for the quarter increased
Operating income as a percentage of revenues for the quarter increased compared to the same period in the prior year primarily due to improved profitability across our contract portfolio and costs related to the settlement of federal tax audits in the prior year, partially offset by higher selling, general and administrative expenses, including recovery of costs from the settlement of a patent infringement matter in the prior year.
Adjusted EBITDA(1) as a percentage of revenues for the quarter decreased to 10.3% from 10.5% for the same period in the prior year primarily due to higher selling, general and administrative expenses, including recovery of costs from the settlement of a patent infringement matter in the prior year, partially offset by improved profitability across our contract portfolio.
Diluted earnings per share for the quarter was
(1)Non-GAAP measure, see Schedule 6 for information about this measure.
Cash Generation and Capital Deployment
Cash flows provided by operating activities for the second quarter increased
During the quarter, SAIC deployed
Subsequent to quarter end, on
Quarterly Dividend Declared
Subsequent to quarter end, on
Backlog and Contract Awards
Net bookings for the quarter were approximately
Notable New and Recompete Awards:
Notable Awards Subsequent to Period End (not included in current quarter bookings):
Fiscal Year 2027 Guidance
The table below summarizes fiscal year 2027 guidance and represents the Company's views as of
| CURRENT | PRIOR | |
| Fiscal Year | Fiscal Year | |
| 2027 Guidance | 2027 Guidance | |
| Revenue | ||
| Organic Growth(1) | (2%) - (0%) | (4%) - (2%) |
| Adjusted EBITDA(1) | ||
| Adjusted EBITDA Margin %(1) | 10.3% - 10.5% | 10.1% - 10.3% |
| Adjusted Diluted EPS(1) | ||
| Free Cash Flow(1) | > | > |
(1)Non-GAAP measure, see Schedule 6 for information about this measure.
Webcast Information
SAIC management will discuss operations and financial results in an earnings conference call beginning at
About SAIC
SAIC® is a premier mission integrator focused on advancing the power of technology and innovation to serve and protect our world. Our robust portfolio of offerings across the defense, space, intelligence, and civilian markets includes secure high-end solutions in mission IT, enterprise IT, engineering services and professional services. We integrate emerging technology, rapidly and securely, into mission critical operations that modernize and enable critical national imperatives.
We are approximately 23,000 strong; driven by mission, united by purpose, and inspired by opportunities. Headquartered in Reston, Virginia, SAIC has annual revenues of approximately $7.3 billion. For more information, visit saic.com. For ongoing news, please visit our newsroom.
Media Contact
Darryn James
Director, Media and Brand Reputation
publicrelations@saic.com
Investor Relations Contact
Jon Raviv
Vice President, Investor Relations
investorrelations@saic.com
GAAP to Non-GAAP Guidance Reconciliation
The Company does not provide a reconciliation of forward-looking adjusted diluted EPS to GAAP diluted EPS, adjusted EBITDA margin to GAAP net income or free cash flow to GAAP net cash flows from operating activities due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. Because certain deductions for non-GAAP exclusions used to calculate net income and cash flows from operating activities may vary significantly based on actual events, the Company is not able to forecast GAAP diluted EPS, GAAP net income or GAAP net cash flows from operating activities with reasonable certainty. The variability of the above charges may have an unpredictable and potentially significant impact on our future GAAP financial results.
Forward-Looking Statements
Certain statements in this release contain or are based on “forward-looking” information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “guidance,” and similar words or phrases. Forward-looking statements in this release may include, among others, estimates of future revenues, operating income, earnings, earnings per share, charges, total contract value, backlog, outstanding shares and cash flows, as well as statements about future dividends, share repurchases and other capital deployment plans. Such statements are not guarantees of future performance and involve risk, uncertainties and assumptions, and actual results may differ materially from the guidance and other forward-looking statements made in this release as a result of various factors. Risks, uncertainties and assumptions that could cause or contribute to these material differences include those discussed in the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Legal Proceedings” sections of our Annual Report on Form 10-K, as updated in any subsequent Quarterly Reports on Form 10-Q and other filings with the SEC, which may be viewed or obtained through the Investor Relations section of our website at www.saic.com or on the SEC’s website at www.sec.gov. Due to such risks, uncertainties and assumptions you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. SAIC expressly disclaims any duty to update any forward-looking statement provided in this release to reflect subsequent events, actual results or changes in SAIC’s expectations. SAIC also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.
Schedule 1:
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
| Three Months Ended | Six Months Ended | ||||||||||||
2026 | 2025 | 2026 | 2025 | ||||||||||
| (in millions, except per share amounts) | |||||||||||||
| Revenues | $ | 1,880 | $ | 1,769 | $ | 3,786 | $ | 3,646 | |||||
| Cost of revenues | 1,641 | 1,554 | 3,298 | 3,222 | |||||||||
| Selling, general and administrative expenses | 87 | 75 | 170 | 164 | |||||||||
| Other operating (income) expense | — | 1 | (13 | ) | — | ||||||||
| Operating income | 152 | 139 | 331 | 260 | |||||||||
| Interest expense, net | 33 | 31 | 66 | 61 | |||||||||
| Other (income) expense, net | — | — | 1 | 5 | |||||||||
| Income before income taxes | 119 | 108 | 264 | 194 | |||||||||
| Income tax (expense) benefit | (17 | ) | 19 | (47 | ) | 1 | |||||||
| Net income | $ | 102 | $ | 127 | $ | 217 | $ | 195 | |||||
| Weighted-average number of shares outstanding: | |||||||||||||
| Basic | 42.4 | 46.7 | 43.1 | 47.1 | |||||||||
| Diluted | 42.8 | 46.8 | 43.4 | 47.3 | |||||||||
| Earnings per share: | |||||||||||||
| Basic | $ | 2.41 | $ | 2.72 | $ | 5.03 | $ | 4.14 | |||||
| Diluted | $ | 2.38 | $ | 2.71 | $ | 5.00 | $ | 4.12 | |||||
Schedule 2:
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
2026 | 2026 | ||||
| (in millions) | |||||
| ASSETS | |||||
| Current assets: | |||||
| Cash and cash equivalents | $ | 126 | $ | 182 | |
| Receivables, net | 996 | 853 | |||
| Prepaid expenses | 129 | 122 | |||
| Other current assets | 28 | 22 | |||
| Total current assets | 1,279 | 1,179 | |||
| 2,943 | 2,944 | ||||
| Intangible assets, net | 697 | 761 | |||
| Property, plant, and equipment, net | 122 | 110 | |||
| Operating lease right of use assets | 210 | 193 | |||
| Other assets | 172 | 167 | |||
| Total assets | $ | 5,423 | $ | 5,354 | |
| LIABILITIES AND EQUITY | |||||
| Current liabilities: | |||||
| Accounts payable | $ | 597 | $ | 500 | |
| Accrued payroll and employee benefits | 334 | 316 | |||
| Other accrued liabilities | 98 | 147 | |||
| Debt, current portion | 33 | 19 | |||
| Total current liabilities | 1,062 | 982 | |||
| Debt, net of current portion | 2,452 | 2,468 | |||
| Operating lease liabilities | 220 | 198 | |||
| Deferred income taxes | 147 | 104 | |||
| Other long-term liabilities | 106 | 102 | |||
| Equity: | |||||
| Total stockholders' equity | 1,436 | 1,500 | |||
| Total liabilities and stockholders' equity | $ | 5,423 | $ | 5,354 | |
Schedule 3:
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| Three Months Ended | Six Months Ended | ||||||||||||||
2026 | 2025 | 2026 | 2025 | ||||||||||||
| (in millions) | |||||||||||||||
| Cash flows from operating activities: | |||||||||||||||
| Net income | $ | 102 | $ | 127 | $ | 217 | $ | 195 | |||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||
| Depreciation and amortization | 39 | 35 | 79 | 71 | |||||||||||
| Stock-based compensation expense | 15 | 10 | 28 | 25 | |||||||||||
| Deferred income taxes | 22 | 110 | 43 | 109 | |||||||||||
| Gain on sales of investments | — | — | (12 | ) | — | ||||||||||
| Other | (2 | ) | (1 | ) | (4 | ) | — | ||||||||
| Increase (decrease) resulting from changes in operating assets and liabilities: | |||||||||||||||
| Receivables | (34 | ) | 58 | (143 | ) | 49 | |||||||||
| Prepaid expenses and other current assets | (29 | ) | (113 | ) | (14 | ) | (107 | ) | |||||||
| Accounts payable and other accrued liabilities | (25 | ) | (117 | ) | 60 | (84 | ) | ||||||||
| Accrued payroll and employee benefits | 56 | 48 | 18 | (3 | ) | ||||||||||
| Operating lease assets and liabilities, net | (1 | ) | (2 | ) | (2 | ) | (4 | ) | |||||||
| Other assets and other long-term liabilities, net | 3 | (33 | ) | 3 | (29 | ) | |||||||||
| Net cash provided by operating activities | 146 | 122 | 273 | 222 | |||||||||||
| Cash flows from investing activities: | |||||||||||||||
| Expenditures for property, plant, and equipment | (15 | ) | (7 | ) | (24 | ) | (15 | ) | |||||||
| Contributions to investments | (3 | ) | (1 | ) | (9 | ) | (7 | ) | |||||||
| Purchases of marketable securities | (5 | ) | — | (9 | ) | (4 | ) | ||||||||
| Sales of marketable securities | 6 | 1 | 11 | 4 | |||||||||||
| Proceeds from sales of investments | — | — | 15 | — | |||||||||||
| Other | 2 | — | 2 | — | |||||||||||
| Net cash used in investing activities | (15 | ) | (7 | ) | (14 | ) | (22 | ) | |||||||
| Cash flows from financing activities: | |||||||||||||||
| Stock repurchased and retired or withheld for taxes on equity awards | (98 | ) | (110 | ) | (286 | ) | (252 | ) | |||||||
| Dividend payments to stockholders | (16 | ) | (17 | ) | (33 | ) | (36 | ) | |||||||
| Principal payments on borrowings | (1 | ) | (546 | ) | (2 | ) | (1,235 | ) | |||||||
| Proceeds from borrowings | — | 557 | — | 1,307 | |||||||||||
| Issuances of stock | 5 | 6 | 10 | 12 | |||||||||||
| Other | (4 | ) | (4 | ) | (4 | ) | (4 | ) | |||||||
| Net cash used in financing activities | (114 | ) | (114 | ) | (315 | ) | (208 | ) | |||||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | 17 | 1 | (56 | ) | (8 | ) | |||||||||
| Cash, cash equivalents and restricted cash at beginning of period | 117 | 55 | 190 | 64 | |||||||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 134 | $ | 56 | $ | 134 | $ | 56 | |||||||
Schedule 4:
SEGMENT OPERATING RESULTS
(Unaudited)
| Three Months Ended | Six Months Ended | ||||||||||||||
2026 | 2025 | 2026 | 2025 | ||||||||||||
| (dollars in millions) | |||||||||||||||
| Revenues | |||||||||||||||
| Defense and Intelligence | $ | 1,449 | $ | 1,374 | $ | 2,915 | $ | 2,807 | |||||||
| Civilian | 431 | 395 | 871 | 839 | |||||||||||
| Total revenues | $ | 1,880 | $ | 1,769 | $ | 3,786 | $ | 3,646 | |||||||
| Adjusted operating income (loss) | |||||||||||||||
| Defense and Intelligence | $ | 138 | $ | 124 | $ | 284 | $ | 239 | |||||||
| Civilian | 56 | 54 | 124 | 106 | |||||||||||
| Corporate | (3 | ) | 4 | 4 | (5 | ) | |||||||||
| Total adjusted operating income | $ | 191 | $ | 182 | $ | 412 | $ | 340 | |||||||
| Adjusted operating margin | |||||||||||||||
| Defense and Intelligence | 9.5 | % | 9.0 | % | 9.7 | % | 8.5 | % | |||||||
| Civilian | 13.0 | % | 13.7 | % | 14.2 | % | 12.6 | % | |||||||
| Total adjusted operating margin | 10.2 | % | 10.3 | % | 10.9 | % | 9.3 | % | |||||||
Second Quarter Defense and Intelligence Results
Revenues for the quarter increased
Adjusted operating income as a percentage of revenues increased compared to the same period in the prior year primarily due to improved profitability across our contract portfolio.
Second Quarter Civilian Results
Revenues for the quarter increased
Adjusted operating income as a percentage of revenues decreased compared to the same period in the prior year primarily due to timing and volume mix in our contract portfolio.
Second Quarter Corporate Results
Adjusted operating loss was
Schedule 5:
BACKLOG
(Unaudited)
The estimated value of our total backlog as of the dates presented was:
| Defense and Intelligence | Civilian | Total SAIC | Defense and Intelligence | Civilian | Total SAIC | ||||||||
| (in millions) | |||||||||||||
| Funded backlog | $ | 2,883 | $ | 935 | $ | 3,818 | $ | 2,511 | $ | 1,061 | $ | 3,572 | |
| Negotiated unfunded backlog | 15,250 | 3,068 | 18,318 | 15,869 | 3,181 | 19,050 | |||||||
| Total backlog | $ | 18,133 | $ | 4,003 | $ | 22,136 | $ | 18,380 | $ | 4,242 | $ | 22,622 | |
Backlog represents the estimated amount of future revenues to be recognized under negotiated contracts and task orders as work is performed and excludes contract awards which have been protested by competitors until the protest is resolved in our favor. SAIC segregates backlog into two categories, funded backlog and negotiated unfunded backlog. Funded backlog for contracts with government agencies primarily represents contracts for which funding is appropriated less revenues previously recognized on these contracts, and does not include the unfunded portion of contracts where funding is incrementally appropriated or authorized by the
Schedule 6:
NON-GAAP FINANCIAL MEASURES
(Unaudited)
This schedule describes the consolidated non-GAAP financial measures included in this earnings release. While we believe that these non-GAAP financial measures provide management and investors with useful information in assessing trends in our ongoing operating performance and may provide greater visibility in understanding our long-term financial performance, they should be considered as supplemental in nature and not as a substitute for financial information prepared in accordance with GAAP. Reconciliations, definitions, and how we believe these measures are useful to management and investors are provided below. Other companies may define similar measures differently.
Non-GAAP Definitions
Organic growth: Organic growth is a performance measure that excludes the impact of acquisitions and divestitures. Organic growth is calculated by taking consolidated revenues and excluding revenues from acquisitions and divestitures during the periods presented, when applicable.
Adjusted operating income: Adjusted operating income is a performance measure that primarily excludes the impact of non-recurring transactions and activities that we do not consider to be indicative of our ongoing operating performance. Adjusted operating income is calculated by taking operating income and excluding amortization of intangible assets, depreciation of property, plant, and equipment, acquisition, integration, restructuring, and impairment costs, and any other material non-recurring costs. Adjusted operating income excludes amortization of intangible assets because we do not have a history of significant acquisition activity, we do not acquire businesses on a predictable cycle, and the amount of an acquisition's purchase price allocated to intangible assets and the related amortization term are unique to each acquisition.
EBITDA and Adjusted EBITDA: EBITDA is a performance measure that is calculated by taking net income and excluding interest and loss on sale of receivables, provision for income taxes, and depreciation and amortization. Adjusted EBITDA is a performance measure that excludes the impact of non-recurring transactions and activities that we do not consider to be indicative of our ongoing operating performance. Adjusted EBITDA is calculated by taking EBITDA and excluding acquisition, integration, restructuring and impairment costs, and any other material non-recurring costs.
Adjusted Diluted Earnings Per Share: Adjusted diluted earnings per share is a performance measure that excludes the impact of non-recurring transactions and activities that we do not consider to be indicative of our ongoing operating performance. Adjusted diluted earnings per share excludes amortization of intangible assets because we do not have a history of significant acquisition activity, we do not acquire businesses on a predictable cycle, and the amount of an acquisition's purchase price allocated to intangible assets and the related amortization term are unique to each acquisition.
Free Cash Flow: Free cash flow is calculated by taking cash flows provided by operating activities less expenditures for property, plant, and equipment and less cash flows from our Master Accounts Receivable Purchasing Agreement ("MARPA") Facility for the sale of certain designated eligible
Acquisition, integration, restructuring and impairment costs: Acquisition and integration costs represent costs incurred related to our acquisitions and subsequent integration with acquired businesses. Restructuring and impairment costs represent costs incurred related to internal reorganizations and initiatives (e.g., Project Orbit), facilities optimization efforts, and impairments of long-lived assets, along with associated depreciation.
Recovery of acquisition, integration, restructuring and impairment costs: Recovery of acquisition, integration, restructuring and impairment costs represents costs recovered through our indirect rates in accordance with Cost Accounting Standards.
Costs related to the settlement of federal tax audits: Costs related to the settlement of federal tax audits represent costs related to the IRS audit settlement for fiscal years 2016 through 2019.
Gain on divestitures, net of transaction costs: The gain on divestitures includes gains recognized related to divestitures, net of transaction costs.
We believe that these performance measures provide management and investors with useful information in assessing trends in our ongoing operating performance and may provide greater visibility in understanding our long-term financial performance.
Schedule 6 (continued):
NON-GAAP FINANCIAL MEASURES
(Unaudited)
Adjusted Operating Income
| Three Months Ended | Six Months Ended | ||||||||||||||
2026 | 2025 | 2026 | 2025 | ||||||||||||
| (dollars in millions) | |||||||||||||||
| Revenues | $ | 1,880 | $ | 1,769 | $ | 3,786 | $ | 3,646 | |||||||
| Operating income | $ | 152 | $ | 139 | $ | 331 | $ | 260 | |||||||
| Operating income as a percentage of revenues | 8.1 | % | 7.9 | % | 8.7 | % | 7.1 | % | |||||||
| Depreciation of property, plant and equipment | 7 | 6 | 15 | 13 | |||||||||||
| Amortization of intangible assets | 32 | 29 | 64 | 58 | |||||||||||
| Acquisition, integration, restructuring and impairment costs | 2 | 1 | 4 | 4 | |||||||||||
| Recovery of acquisition, integration, restructuring and impairment costs | (1 | ) | — | (2 | ) | (2 | ) | ||||||||
| Costs related to the settlement of federal tax audits | — | 7 | 1 | 7 | |||||||||||
| Gain on divestitures, net of transaction costs | (1 | ) | — | (1 | ) | — | |||||||||
| Adjusted operating income(1) | $ | 191 | $ | 182 | $ | 412 | $ | 340 | |||||||
| Adjusted operating income as a percentage of revenues | 10.2 | % | 10.3 | % | 10.9 | % | 9.3 | % | |||||||
(1)Non-GAAP measure, see above for definition.
Schedule 6 (continued):
NON-GAAP FINANCIAL MEASURES
(Unaudited)
EBITDA and Adjusted EBITDA
| Three Months Ended | Six Months Ended | ||||||||||||||
2026 | 2025 | 2026 | 2025 | ||||||||||||
| (dollars in millions) | |||||||||||||||
| Revenues | $ | 1,880 | $ | 1,769 | $ | 3,786 | $ | 3,646 | |||||||
| Net income | $ | 102 | $ | 127 | $ | 217 | $ | 195 | |||||||
| Interest expense, net and loss on sale of receivables | 35 | 34 | 70 | 68 | |||||||||||
| Income tax expense (benefit) | 17 | (19 | ) | 47 | (1 | ) | |||||||||
| Depreciation and amortization | 39 | 35 | 79 | 71 | |||||||||||
| EBITDA(1) | 193 | 177 | 413 | 333 | |||||||||||
| EBITDA as a percentage of revenues | 10.3 | % | 10.0 | % | 10.9 | % | 9.1 | % | |||||||
| Acquisition, integration, restructuring and impairment costs | 2 | 1 | 4 | 4 | |||||||||||
| Recovery of acquisition, integration, restructuring and impairment costs | (1 | ) | — | (2 | ) | (2 | ) | ||||||||
| Costs related to the settlement of federal tax audits | — | 7 | 1 | 7 | |||||||||||
| Gain on divestitures, net of transaction costs | (1 | ) | — | (1 | ) | — | |||||||||
| Adjusted EBITDA(1) | $ | 193 | $ | 185 | $ | 415 | $ | 342 | |||||||
| Adjusted EBITDA as a percentage of revenues | 10.3 | % | 10.5 | % | 11.0 | % | 9.4 | % | |||||||
(1)Non-GAAP measure, see above for definition.
Schedule 6 (continued):
NON-GAAP FINANCIAL MEASURES
(Unaudited)
Adjusted Diluted Earnings Per Share
| Three Months Ended | ||||||||||||||||||||||
| (in millions, except per share amounts) | ||||||||||||||||||||||
| As Reported | Amortization of intangible assets | Acquisition, integration, restructuring and impairment costs | Recovery of acquisition, integration, restructuring and impairment costs | Gain on divestitures, net of transaction costs | Non-GAAP results(1) | |||||||||||||||||
| Income before income taxes | $ | 119 | $ | 32 | $ | 2 | $ | (1 | ) | $ | (1 | ) | $ | 151 | ||||||||
| Income tax (expense) benefit | (17 | ) | (5 | ) | — | — | — | (22 | ) | |||||||||||||
| Net income | $ | 102 | $ | 27 | $ | 2 | $ | (1 | ) | $ | (1 | ) | $ | 129 | ||||||||
| Diluted EPS | $ | 2.38 | $ | 0.63 | $ | 0.04 | $ | (0.02 | ) | $ | (0.02 | ) | $ | 3.01 | ||||||||
| Three Months Ended | ||||||||||||||
| (in millions, except per share amounts) | ||||||||||||||
| As Reported | Amortization of intangible assets | Acquisition, integration, restructuring and impairment costs | Costs related to the settlement of federal tax audits | Non-GAAP results(1) | ||||||||||
| Income before income taxes | $ | 108 | $ | 29 | $ | 1 | $ | 7 | $ | 145 | ||||
| Income tax (expense) benefit | 19 | 6 | — | — | 25 | |||||||||
| Net income | $ | 127 | $ | 35 | $ | 1 | $ | 7 | $ | 170 | ||||
| Diluted EPS | $ | 2.71 | $ | 0.75 | $ | 0.02 | $ | 0.15 | $ | 3.63 | ||||
(1)Non-GAAP measure, see above for definition.
Schedule 6 (continued):
NON-GAAP FINANCIAL MEASURES
(Unaudited)
Adjusted Diluted Earnings Per Share
| Six Months Ended | |||||||||||||||||||||||||
| (in millions, except per share amounts) | |||||||||||||||||||||||||
| As Reported | Amortization of intangible assets | Acquisition, integration, restructuring and impairment costs | Recovery of acquisition, integration, restructuring and impairment costs | Costs related to the settlement of federal tax audits | Gain on divestitures, net of transaction costs | Non-GAAP results(1) | |||||||||||||||||||
| Income before income taxes | $ | 264 | $ | 64 | $ | 4 | $ | (2 | ) | $ | 1 | $ | (1 | ) | $ | 330 | |||||||||
| Income tax (expense) benefit | (47 | ) | (12 | ) | — | — | — | — | (59 | ) | |||||||||||||||
| Net income | $ | 217 | $ | 52 | $ | 4 | $ | (2 | ) | $ | 1 | $ | (1 | ) | $ | 271 | |||||||||
| Diluted EPS | $ | 5.00 | $ | 1.20 | $ | 0.09 | $ | (0.05 | ) | $ | 0.02 | $ | (0.02 | ) | $ | 6.24 | |||||||||
| Six Months Ended | ||||||||||||||||||
| (in millions, except per share amounts) | ||||||||||||||||||
| As Reported | Amortization of intangible assets | Acquisition, integration, restructuring and impairment costs | Recovery of acquisition, integration, restructuring and impairment costs | Costs related to the settlement of federal tax audits | Non-GAAP results(1) | |||||||||||||
| Income before income taxes | $ | 194 | $ | 58 | $ | 4 | $ | (2 | ) | $ | 7 | $ | 261 | |||||
| Income tax (expense) benefit | 1 | — | — | — | — | 1 | ||||||||||||
| Net income | $ | 195 | $ | 58 | $ | 4 | $ | (2 | ) | $ | 7 | $ | 262 | |||||
| Diluted EPS | $ | 4.12 | $ | 1.23 | $ | 0.08 | $ | (0.04 | ) | $ | 0.15 | $ | 5.54 | |||||
(1)Non-GAAP measure, see above for definition.
Schedule 6 (continued):
NON-GAAP FINANCIAL MEASURES
(Unaudited)
Free Cash Flow
| Three Months Ended | Six Months Ended | ||||||||||||||
2026 | 2025 | 2026 | 2025 | ||||||||||||
| (in millions) | |||||||||||||||
| Net cash provided by operating activities | $ | 146 | $ | 122 | $ | 273 | $ | 222 | |||||||
| Expenditures for property, plant, and equipment | (15 | ) | (7 | ) | (24 | ) | (15 | ) | |||||||
| Cash used from (provided by) MARPA Facility | — | 35 | — | (101 | ) | ||||||||||
| Free cash flow(1) | $ | 131 | $ | 150 | $ | 249 | $ | 106 | |||||||
| FY27 Guidance | |
| Net cash provided by operating activities | > |
| Expenditures for property, plant, and equipment | Approximately |
| Free cash flow(1) | > |
(1)Non-GAAP measure, see above for definition.
Source: 